The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Carmelo Scarpignato

Division of Gastroenterology

Department of Clinical Sciences

University of Parma

Italy

[email]@tin.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Gastroenterology, Department of Clinical Sciences, University of Parma, Italy. 2010
  • Laboratory of Clinical Pharmacology, School of Medicine and Dentistry, University of Parma, Via Volturno, Italy. 1999 - 2008
  • Laboratory of Clinical Pharmacology, Department of Human Anatomy, Pharmacology and Forensic Sciences, School of Medicine and Dentistry, Italy. 2005 - 2008
  • Department of Gastroenterology and Hepatology, Faculty of Medicine, University of Nantes, France. 1999

References

  1. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Scarpignato, C., Hunt, R.H. Gastroenterol. Clin. North Am. (2010) [Pubmed]
  2. NSAID-induced intestinal damage: are luminal bacteria the therapeutic target? Scarpignato, C. Gut (2008) [Pubmed]
  3. Proton pump inhibitors: the beginning of the end or the end of the beginning?. Scarpignato, C., Hunt, R.H. Curr. Opin. Pharmacol (2008) [Pubmed]
  4. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Scarpignato, C., Pelosini, I. Digestion (2006) [Pubmed]
  5. Acid suppression therapy: where do we go from here?. Scarpignato, C., Pelosini, I., Di Mario, F. Dig. Dis (2006) [Pubmed]
  6. Review article: the opportunities and benefits of extended acid suppression. Scarpignato, C., Pelosini, I. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  7. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Scarpignato, C., Pelosini, I. Chemotherapy (2005) [Pubmed]
  8. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle. Scarpignato, C. Dig. Liver. Dis (2005) [Pubmed]
  9. Towards the ideal regimen for Helicobacter pylori eradication: the search continues. Scarpignato, C. Dig. Liver. Dis (2004) [Pubmed]
  10. Somatostatin analogs for cancer treatment and diagnosis: an overview. Scarpignato, C., Pelosini, I. Chemotherapy (2001) [Pubmed]
  11. New therapeutic modalities for benign oesophageal disease: an overview. Scarpignato, C. Dig. Liver. Dis (2001) [Pubmed]
  12. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. Scarpignato, C., Pelosini, I. Can. J. Gastroenterol. (1999) [Pubmed]
  13. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Scarpignato, C., Pelosini, I. Ital. J. Gastroenterol. Hepatol (1999) [Pubmed]
  14. Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety. Scarpignato, C., Pelosini, I. Digestion (1999) [Pubmed]
 
WikiGenes - Universities